D

DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA (Private limited company)

BE 0894.219.244 Active ●Oudebaan 258C, 3000 Louvain

DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0894.219.244. It was founded on 10-12-2007. Its registered office is in Leuven. Its main activity is: Human health activities. Its annual accounts for 2025 report equity of € 903 020 and a profit of € 61 789. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for 3 of its last 4 financial years.

Information last updated on 25-10-2026.

Company information

Status
Active
Enterprise number
BE 0894.219.244
VAT registered
Yes
Founded
10-12-2007
Latest accounts
2025
Employees
-
Region
Flanders
Establishments
1
Filing record
On time 3 of 4 years
Peppol e-invoicing
Registered
Registered office
Oudebaan 258C, 3000 Louvain
Main activity
Human health activities
NACE activities
86210 Activités de médecine générale
86995 Activités dans le domaine de l’alimentation

Key figures of DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ 61 789-9 %€ 67 789-17 %€ 81 458+1 %€ 80 677
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 903 020+7 %€ 841 231+9 %€ 773 442+12 %€ 691 984
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 917 794+5 %€ 872 097+9 %€ 801 850+10 %€ 726 002
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ 131 792-8 %€ 142 918-11 %€ 160 833+19 %€ 134 740
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
----

Financial estimate

Financial health grade A, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
1 mandate on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity in Leuven.

CompanyTown
Katholieke Universiteit te Leuven 3000 Leuven
BIOMEDICAL SYSTEMS 3000 Leuven
Megabite & Co 3000 Leuven
FRESA 3000 Leuven
J. LEMAIRE & PARTNERS 3000 Leuven
HOSPEX 3000 Leuven
NEW OFIR 3000 Leuven
Opdebeeck & Preda Orthodontie 3000 Leuven
Looking for more information about DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA still active? Yes. The Crossroads Bank for Enterprises lists DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA as active.

What is the VAT number of DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA? The VAT number of DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA is BE 0894.219.244.

When was DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA founded? DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA was founded on 10-12-2007.

What is the address of DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA? The current registered office of DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA is Oudebaan 258C, 3000 Louvain.

When did DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA last file annual accounts? The latest annual accounts of DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA were filed on 23-09-2026.

Does DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA file its annual accounts on time? DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA filed its annual accounts within the legal deadline for 3 of its last 4 financial years. Late: 2025.

Is DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA financially healthy? Addrly gives DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA profitable? The annual accounts of DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA for 2025 show a profit of € 61 789.

What is the equity of DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA? The equity of DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA was € 903 020 at the close of the 2025 financial year.

Who are the directors of DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA? The annual accounts of DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA record 1 mandate. The name, role and dates are visible with a free account.

Can DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA receive Peppol e-invoices? Yes. DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA is registered on the Peppol network and can receive structured electronic invoices.

What does DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA do? The main activity of DR.DE CLIPPEL MARC ALGEMENE GENEESKUNDE BVBA is: Human health activities.

Sources

How Addrly builds and refreshes this data